Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus
Common side effects include nausea, constipation, vomiting, and diarrhea, typically mild and temporary
Cytokine Production: GLP-1R activation directly inhibits the production of pro-inflammatory cytokines (TNF-, IL-1, IL-6) and increases anti-inflammatory mediators like adiponectin
Other compounds in the pipeline include survodutide , mazdutide , CagriSema , and orforglipron
Essential Amino Acids (EAAs) EAAs are the building blocks of protein that the body cannot produce on its own
Each vial contains high-purity lyophilized peptide blend designed for precision laboratory applications